Results 61 to 70 of about 1,412 (173)
, 2018 PURPOSE: Identification of pathologic parathyroid glands in primary hyperparathyroidism, traditionally based on neck ultrasound (US) and/or 99mTc-Sestamibi scintigraphy, can be challenging.
Hodolic M. +7 more
core +1 more source
Archives of Endocrinology and Metabolism, 2019 Objective: To define serum parathyroid hormone (PTH) reference values in carefully selected subjects following the recommended pre-analytical guidelines.
Pedro Weslley Rosario +1 more
doaj +1 more source
Prognosis and Phenotypes of Advanced Head and Neck Carcinoma Associated With Hypercalcemia
Head &Neck, Volume 47, Issue 8, Page 2174-2182, August 2025.ABSTRACT Purpose Hypercalcemia is the most common metabolic disorder in cancer, affecting 10%–20% of patients with advanced malignancies, including squamous cell carcinoma of the head and neck (HNSCC), though its prognostic significance remains poorly studied.
Elodie Mamou +5 more
wiley +1 more source
Clinical Case Reports, Volume 13, Issue 7, July 2025.ABSTRACT Primary hyperparathyroidism may present with a diagnostic challenge due to its nonspecific initial symptoms, often delaying diagnosis. Nephrolithiasis, a common presentation, is often treated in isolation without consideration of an underlying hyperparathyroidism.
Prince Yaw Boahene +5 more
wiley +1 more source
Cancer Reports, Volume 8, Issue 3, March 2025.ABSTRACT Background Hypercalcemia is a common complication of advanced malignancy and a palliative care emergency. Its incidence increases in the later stages of the disease and is linked to a poor prognosis. Understanding the prevalence, clinical characteristics, and factors associated with malignancy‐related hypercalcemia is crucial for developing ...
Rafsana Rouf +3 more
wiley +1 more source
Is parathyroidectomy safe and effective in patients with normocalcemic primary hyperparathyroidism?
, 2018 Purpose: Indications and advantages of parathyroidectomy in patients with normocalcemic primary hyperparathyroidism (NHPT) are still matter of debate. We aimed to compare clinical presentation and surgical outcome between normocalcemic and hypercalcemic ...
de Crea, Carmela +12 more
core +1 more source
Normocalcemic Primary Hyperparathyroidism
, 2012 Normocalcemic primary hyperparathyroidism is a new entity which possibly represents a fruste form of the classic clinically symptomatic disease and which has generated a considerable scientific interest in the last decade. Its official recognition is just as recent as in 2008, when an international conference took place for clarifying its nature and ...
Maria-Teresa Julian +3 more
openaire +2 more sources
Parathyromatosis: A Challenging Management in a Young Girl Case Report With Literature Review
Case Reports in Endocrinology, Volume 2025, Issue 1, 2025.Parathytomatosis is a rare cause of persistent or recurrent hyperparathyroidism, defined by the presence of hyperfunctioning parathyroid tissues scattered throughout the neck and mediastinum. Preoperative diagnosis and localization of all the seeded parathyroid tissue is difficult, therefore, many imaging modalities are needed to determine the ...
Grace Jrad +5 more
wiley +1 more source
Health Science Reports, Volume 7, Issue 12, December 2024.ABSTRACT Background and Aim Hypercalcemia is one of the most common complications of advanced malignancy. Treatment of hypercalcemia among advanced cancer patients often gives rise to complex ethical issues. This study aims to explore treatment outcomes of hypercalcemia among advanced cancer patients so that palliative care physicians can design cost ...
Rafsana Rouf +3 more
wiley +1 more source
, 2023 20.500.12530/87854The aim of this study was to analyze the prevalence of primary and secondary hyperparathyroidism in patients with primary aldosteronism (PA), and its implication on cardiovascular and metabolic outcomes.
Ana GARCÍA CANO +13 more
core +1 more source